PlatinumLED Therapy Lights

Overview

PlatinumLED Therapy Lights is the technical-spec leader in the consumer red-light panel category — founded 2010 in Tempe AZ, with a product line built around the BIOMAX 7-wavelength architecture that makes the brand structurally distinct from every competitor in the space.

Where Joovv (founded 2016) markets clinical-grade dose at standard 660+810nm wavelengths, and Mito Red Light (2018) competes on price-per-watt at standard wavelengths, PlatinumLED’s BIOMAX panels deliver 7 wavelengths simultaneously: 480nm (blue/circadian), 580nm (yellow/inflammation), 630nm (red/collagen), 660nm (deep red/mitochondrial), 810nm (NIR/standard), 830nm (NIR/optimized), and 1060nm (deep-NIR) — the last wavelength is the structural differentiator no other consumer brand offers at scale.

The 1060nm inclusion is editorially significant. Deep-NIR penetrates further into tissue than the standard 810nm, which means BIOMAX panels can theoretically deliver dose to deeper anatomical structures (muscle, joint, organ-level depths) that shorter NIR wavelengths cannot reach efficiently.

The honest editorial caveat: PlatinumLED is FDA-registered, not FDA-cleared. The brand’s clearance claims should be evaluated against the same standard as all other FDA-registered red-light competitors — registration is not clearance.

What We Measured

Note: This review is based on PlatinumLED’s published BIOMAX specifications, published irradiance and spectrum measurements, 60-day-trial policy documentation, and aggregated user reports. Hands-on testing of a specific BIOMAX panel (irradiance verification, dose validation, build quality) is pending.

The 7-wavelength BIOMAX architecture

This is the brand’s central technical differentiator:

• 480nm: blue/circadian range (limited in panel applications)
• 580nm: yellow/amber, surface-skin / inflammation
• 630nm: red, collagen / aesthetic skin
• 660nm: deep red, mitochondrial / cellular-energy primary
• 810nm: NIR, standard mid-depth tissue penetration
• 830nm: NIR, slight optimization beyond 810nm
• 1060nm: deep-NIR, deepest tissue penetration in consumer red-light

The 1060nm wavelength is the structural differentiator. Most competitors deliver 2 wavelengths (660+810nm); a few deliver 3–4. PlatinumLED’s BIOMAX 7 wavelength architecture is unique at consumer pricing.

The trade-off: delivery dose per wavelength is divided across 7 emitter types. Total panel power is high (BIOMAX 900: 900W rated, 300+ mW/cm² at 6 inches), but the per-wavelength share of that dose is necessarily smaller than a dedicated 2-wavelength panel of equivalent total wattage.

For most biohacking applications (recovery, energy, skin), the 660 + 810nm pair carries 80%+ of the relevant biological effect. The additional 5 wavelengths add marginal but real spectrum coverage. The 1060nm is the most-novel addition — clinical-research portfolio is still accumulating.

The 60-day risk-free trial

This is structurally meaningful for high-ticket purchases ($349–$1,600). PlatinumLED’s 60-day trial covers full money-back if dissatisfied. For comparison: Joovv (30-day return), Mito Red Light (60-day), Hooga Health (60-day).

A 60-day trial materially de-risks the purchase decision. Red-light therapy benefits typically appear in 4–8 weeks of consistent use; 60 days provides enough runway to actually evaluate the device against personal outcomes.

The product line

PlatinumLED’s BIOMAX catalog covers:

• BIOMAX 300 (~$349): smallest panel, targeted-area treatment
• BIOMAX 450 (~$549): mid-tier, suitable for half-body
• BIOMAX 600 (~$849): full-torso coverage
• BIOMAX 900 (~$1,200): full-body / large-area coverage
• BIOMAX 7-Wavelength Panel (~$1,600): top-tier dual-mounting

The pricing is notably accessible vs Joovv (BIOMAX 600 at $849 vs Joovv Solo 3.0 at $1,995 for similar coverage). The cost-per-watt math favors PlatinumLED structurally.

The FDA-registered (not cleared) caveat

This is the central editorial honesty point. PlatinumLED is FDA-registered as a manufacturer; the BIOMAX panels are not 510(k)-cleared for any specific indication.

FDA-registered = the manufacturer registered with FDA as a producer. Administrative listing only.

FDA-cleared (510k) = the device is cleared for a specific indication based on substantial-equivalence review.

PlatinumLED’s marketing should be evaluated against this distinction. The BIOMAX panels are well-engineered; the regulatory positioning matches CurrentBody Skin’s competitor LED-mask architecture (cleared) less precisely than buyers might assume from PlatinumLED’s marketing.

3-Year Cost of Ownership

Use case	Cost
BIOMAX 300 (one-time)	~$349
BIOMAX 600 (one-time)	~$849
3-year ownership — single device	~$349–$849

Compare: Joovv Solo 3.0 ($1,995), Mito Red Light Hybrid ($499), CurrentBody Skin LED Mask ($469), Hooga PRO1500 ($899).

PlatinumLED’s pricing is meaningfully accessible vs Joovv at equivalent panel sizes. The cost-per-watt is among the best in the consumer-tier red-light category.

Regulatory Status

FDA-Registered, NOT FDA-Cleared. The BIOMAX panels are FDA-registered as products manufactured by a registered facility. There is no 510(k) clearance for any specific indication.

Buyers should evaluate PlatinumLED’s regulatory positioning honestly: the brand is well-engineered and well-priced, but it does not carry the same regulatory rigor as CurrentBody Skin’s 510(k)-cleared LED Mask.

When PlatinumLED Makes Sense — And When It Doesn’t

Strong fit:

• You want the most sophisticated spectrum in consumer red-light — 7 wavelengths including 1060nm deep-NIR
• You value risk-free trial periods — 60 days is meaningfully de-risked
• You want panel-form-factor red light at accessible pricing — substantially below Joovv at equivalent coverage
• You’re a biohacker willing to evaluate emerging-methodology wavelengths (1060nm) on accumulating clinical evidence
• You don’t need 510(k) clearance for personal use cases

Weaker fit:

• You need actual FDA 510(k) clearance — CurrentBody Skin (LED Mask) or LightStim (multiple devices) are the right options
• You want maximum delivery dose at primary biohacker wavelengths (660+810nm) — dedicated 2-wavelength panels deliver more dose per dollar at those specific wavelengths
• You want strong brand-marketing presence — PlatinumLED’s marketing is functional but not category-leading
• You want independent third-party irradiance verification — Joovv has been more aggressive on this dimension

Verdict: Recommended

PlatinumLED earns a recommended verdict on the strength of its category-unique 7-wavelength BIOMAX architecture (the only consumer brand offering 1060nm deep-NIR at scale), competitive pricing vs Joovv at equivalent panel coverage, 60-day risk-free trial that materially de-risks the purchase, and made-in-USA consumer-direct distribution.

For buyers seeking the most sophisticated spectrum design in the consumer red-light panel category, PlatinumLED is structurally the leading choice. The 1060nm deep-NIR is a genuine technical differentiator no other major brand offers, and the price points are meaningfully more accessible than Joovv’s equivalents.

The honest editorial framing: PlatinumLED is FDA-registered, not FDA-cleared — buyers should not over-weight PlatinumLED’s regulatory positioning. For users seeking actual 510(k) clearance, CurrentBody Skin (LED Mask) or LightStim (multiple device line) are structurally better. For users prioritizing technical spectrum sophistication and value, PlatinumLED is one of the strongest options in the consumer market.

Changelog

• 2026-05-06: Initial review published based on PlatinumLED’s published BIOMAX specifications, irradiance and spectrum documentation, 60-day-trial policy, and aggregated user-report data.